UMC Event Details

Event Name: Medical Grand Rounds
Event Description: "Incretin Therapy: A New Paradigm in the Treatment of Type 2 Diabetes" John Tayek, MD - Professor of Medicine, Dept. of Medicine, Harbor-UCLA Medical Center - Supported by Amlyn Pharma & Eli Lilly - Objectives: Summarize the comorbidities associated with diabetes; Distinguish key pathophysiologic characteristics of diabetes including insulin resistance, beta-cell dysfunction and incretin abnormalities; Describe the role of incretin hormones in regulating glucose metabolism; Compare the advantages and disadvantages of incretin therapy versus traditional therapies in the treatment of type 2 diabetes

Event Date: 11/20/2009
Event Time: 7:30:00 AM

Event Location: 2040 W. Charleston Blvd. 6th Flr, CR E & F
Event Cost: Free